Mechanisms of acquired resistance to c-Src kinase inhibitor in triple negative breast cancer

被引：0
|
作者：
Gilani, Rabia A.
Lachacz, Eric J.
Phadke, Sameer
Bao, Li Wei
Cheng, Xu
Jiagge, Evelyn M.
Soellner, Matthew B.
Merajver, Sofia D.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-4117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4117
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A role of active c-Src in progression of lobular breast cancer
    Yoon, H. -S.
    Zou, D.
    Guilford, P.
    Humar, B.
    [J]. VIRCHOWS ARCHIV, 2014, 465 : S96 - S96
  • [32] Active recombinant human tyrosine kinase c-Yes: Expression in baculovirus system, purification, comparison to c-Src, and inhibition by a c-Src inhibitor
    Susa, M
    Luong-Nguyen, NH
    Crespo, J
    Maier, R
    Missbach, M
    McMaster, G
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2000, 19 (01) : 99 - 106
  • [33] Tumor concentration of metformin is a determinant factor of its regulation of fatty acid β-oxidation and c-Src pathway in triple-negative breast cancer
    Park, Junhyoung
    Jung, Kwang Hwa
    Jia, Dongya
    Yang, Sukjin
    Attri, Kuldeep S.
    Ahn, Songyeon
    Murthy, Divya
    Ghidey, Meron
    Chatterjee, Somik
    Pedroza, Diego A.
    Tiwari, Abha
    Kim, Suna
    Creighton, Chad C.
    Putluri, Nagireddy
    Rosen, Jeffrey M.
    Onuchic, Jose N.
    Goga, Andrei
    Kaipparettu, Benny A.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [34] Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
    Wanjun Lin
    Jiajun Huang
    Zhongwen Yuan
    Senling Feng
    Ying Xie
    Wenzhe Ma
    [J]. Scientific Reports, 7
  • [35] Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
    Lin, Wanjun
    Huang, Jiajun
    Yuan, Zhongwen
    Feng, Senling
    Xie, Ying
    Ma, Wenzhe
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [36] Selective Proteolysis to Study the Global Conformation and Regulatory Mechanisms of c-Src Kinase
    Agius, Michael P.
    Ko, Kristin S.
    Johnson, Taylor K.
    Kwarcinski, Frank E.
    Phadke, Sameer
    Lachacz, Eric J.
    Soellner, Matthew B.
    [J]. ACS CHEMICAL BIOLOGY, 2019, 14 (07) : 1556 - 1563
  • [37] Active c-Src has prognostic and therapeutic value in ER-negative breast cancer.
    Arnaout, A.
    Yang, L.
    Holloway, C.
    Steven, N.
    Sun, P.
    Kahn, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 556S - 556S
  • [38] Curcumin Synergizes With C-SRC Inhibitor Dasatinib in Inhibiting Colon Cancer
    Nautiyal, Jyoti
    Banerjee, Sanjeev
    Kanwar, Shailender S.
    Sarkar, Fazlul
    Majumdar, Adhip P.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S503 - S504
  • [39] Activation mechanism of c-src tyrosine kinase
    Shukla, Diwakar
    Meng, Yilin
    Roux, Benoit
    Pande, Vijay S.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [40] Differential interactions between c-Src and c-Met mediate resistance to c-Src inhibitors
    Sen, Banibrata
    Peng, Shaohua
    Saigal, Babita
    Williams, Michelle
    Johnson, Faye M.
    [J]. CANCER RESEARCH, 2011, 71
12345